As presidential nominees Hillary Clinton and Donald Trump were set to take the stage for their first debate, Sen. Amy Klobuchar (D-MN) told stakeholders at a Center for American Progress Action Fund briefing Monday (Sept. 26) she hoped drug pricing would be raised because it is the “number one thing” she has heard from a number of constituents. The center, in turn, released an issue brief that proposes a drug price negotiation process for Medicare and private payers that incorporates...